PreveCeutical Engages New to the Street for Production & Broadcasting Services
VANCOUVER, BC, Aug. 31, 2023 /PRNewswire/ – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a Service Agreement dated effective September 1, 2023 (the “Agreement“) with New to the Street Group LLC (“NTTS“), whereby NTTS will provide production and broadcasting services (the “Services“) to the Company involving television, production, media analysis, and procurement.
Related news for (PRVCF)
- PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
- PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
- PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application
- PreveCeutical Showcases Dynamic Evolution in AI Strategy